Ultragenyx Pharmaceutical (RARE) Other Gross PP&E Adjustments: 2016-2024
Historic Other Gross PP&E Adjustments for Ultragenyx Pharmaceutical (RARE) over the last 5 years, with Dec 2024 value amounting to $378.4 million.
- Ultragenyx Pharmaceutical's Other Gross PP&E Adjustments rose 1.19% to $378.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $706.7 million, marking a year-over-year increase of 131.43%. This contributed to the annual value of $378.4 million for FY2024, which is 1.19% up from last year.
- As of Q4 2024, Ultragenyx Pharmaceutical's Other Gross PP&E Adjustments stood at $378.4 million, which was up 1.19% from $374.0 million recorded in Q4 2023.
- Ultragenyx Pharmaceutical's 5-year Other Gross PP&E Adjustments high stood at $378.4 million for Q4 2024, and its period low was -$38.6 million during Q2 2021.
- Its 3-year average for Other Gross PP&E Adjustments is $98.7 million, with a median of -$22.9 million in 2023.
- Per our database at Business Quant, Ultragenyx Pharmaceutical's Other Gross PP&E Adjustments slumped by 55.61% in 2020 and then soared by 122.14% in 2021.
- Ultragenyx Pharmaceutical's Other Gross PP&E Adjustments (Quarterly) stood at $70.4 million in 2020, then skyrocketed by 122.14% to $156.3 million in 2021, then spiked by 90.05% to $297.1 million in 2022, then climbed by 25.85% to $374.0 million in 2023, then grew by 1.19% to $378.4 million in 2024.
- Its Other Gross PP&E Adjustments was $378.4 million in Q4 2024, compared to $374.0 million in Q4 2023 and -$26.4 million in Q3 2023.